IVIVR establishment and BE predictions
In Silico trial to establish a IVIVR model based on Bioequivalence outcome
In Silico trial to establish a IVIVR model based on Bioequivalence outcome
In silico Quantitative Structure-Toxicity Relationship (QSTR) Model for Predicting Toxicity of Aromatic Aldehydes using Extended Topochemical Atom (ETA) Indices.
In silico SD Bioequivalence trial to replace clinical trial
Design from Scratch an Influenza Vaccine
In Silico trial to replace Bioequivalence trial for non-proportional formulation
In Silico trial to establish a IVIVR model based on Bioequivalence outcome
PK sparse sampling scheme optimization for phase III clinical trial in Oncology
The Sponsor intended to have a bio-predictive media followed by IVIVR model to predict the plasma exposure for different in-vitro release and different doses. The
Enhancing the efficacy of a COVID-19 Vaccine
In silico MD clinical trial in children 12-18 years of age
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved